Dr. David R. Parkinson

Dr. David R. Parkinson has held various roles in the biotechnology industry since 1997. Their most recent position is President & Chief Executive Officer at ESSA Pharma, a position they have held since 2016. Prior to this, they held the position of Chairman of the Board & Scientific Co-Founder at Refuge Biotechnologies since 2017, and Director of the Board of Directors at CTI BioPharma since 2017. Dr. David R. was also Director of the Board of Directors at 3SBio Inc. since 2015 and Tocagen since 2015. Additionally, they were a Venture Partner at New Enterprise Associates since 2012, President & Chief Executive Officer at Nodality Inc. since 2007, Senior Vice President at Biogen Idec since 2006, Vice President of Oncology Research and Development at Amgen since 2003, and Vice President of Oncology Clinical Development at Novartis since 1997.

Dr. David R. Parkinson obtained their MD from the University of Toronto between 1969 and 1974, specializing in Medicine.